[1]
|
Murray, C.J.L., Aravkin, A.Y., Zheng, P., Abbafati, C., Abbas, K.M., Abbasi-Kangevari, M., et al. (2020) Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1223-1249. https://doi.org/10.1016/s0140-6736(20)30752-2
|
[2]
|
Zhou, B., Carrillo-Larco, R.M., Danaei, G., Riley, L.M., Paciorek, C.J., Stevens, G.A., et al. (2021) Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants. The Lancet, 398, 957-980. https://doi.org/10.1016/s0140-6736(21)01330-1
|
[3]
|
Desai, A.N. (2020) High Blood Pressure. Journal of the American Medical Association, 324, 1254-1255. https://doi.org/10.1001/jama.2020.11289
|
[4]
|
Fuchs, F.D. and Whelton, P.K. (2020) High Blood Pressure and Cardiovascular Disease. Hypertension, 75, 285-292. https://doi.org/10.1161/hypertensionaha.119.14240
|
[5]
|
Valenzuela, P.L., Carrera-Bastos, P., Gálvez, B.G., Ruiz-Hurtado, G., Ordovas, J.M., Ruilope, L.M., et al. (2020) Lifestyle Interventions for the Prevention and Treatment of Hypertension. Nature Reviews Cardiology, 18, 251-275. https://doi.org/10.1038/s41569-020-00437-9
|
[6]
|
Ortega, F.B., Lavie, C.J. and Blair, S.N. (2016) Obesity and Cardiovascular Disease. Circulation Research, 118, 1752-1770. https://doi.org/10.1161/circresaha.115.306883
|
[7]
|
Powell-Wiley, T.M., Poirier, P., Burke, L.E., Després, J., Gordon-Larsen, P., Lavie, C.J., et al. (2021) Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 143, e984-e1010. https://doi.org/10.1161/cir.0000000000000973
|
[8]
|
Zhu, Q. and Scherer, P.E. (2017) Immunologic and Endocrine Functions of Adipose Tissue: Implications for Kidney Disease. Nature Reviews Nephrology, 14, 105-120. https://doi.org/10.1038/nrneph.2017.157
|
[9]
|
Tesauro, M., Mascali, A., Franzese, O., Cipriani, S., Cardillo, C. and Di Daniele, N. (2012) Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin. International Journal of Hypertension, 2012, 1-7. https://doi.org/10.1155/2012/943605
|
[10]
|
Cildir, G., Akıncılar, S.C. and Tergaonkar, V. (2013) Chronic Adipose Tissue Inflammation: All Immune Cells on the Stage. Trends in Molecular Medicine, 19, 487-500. https://doi.org/10.1016/j.molmed.2013.05.001
|
[11]
|
Zhang, Z., Zhao, L., Zhou, X., Meng, X. and Zhou, X. (2023) Role of Inflammation, Immunity, and Oxidative Stress in Hypertension: New Insights and Potential Therapeutic Targets. Frontiers in Immunology, 13, Article 1098725. https://doi.org/10.3389/fimmu.2022.1098725
|
[12]
|
González-Muniesa, P., Mártinez-González, M., Hu, F.B., Després, J., Matsuzawa, Y., Loos, R.J.F., et al. (2017) Obesity. Nature Reviews Disease Primers, 3, Article No. 17034. https://doi.org/10.1038/nrdp.2017.34
|
[13]
|
Neeland, I.J., Ross, R., Després, J., Matsuzawa, Y., Yamashita, S., Shai, I., et al. (2019) Visceral and Ectopic Fat, Atherosclerosis, and Cardiometabolic Disease: A Position Statement. The Lancet Diabetes & Endocrinology, 7, 715-725. https://doi.org/10.1016/s2213-8587(19)30084-1
|
[14]
|
Amato, M.C. and Giordano, C. (2014) Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction. International Journal of Endocrinology, 2014, 1-7. https://doi.org/10.1155/2014/730827
|
[15]
|
Amato, M.C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., et al. (2010) Visceral Adiposity Index. Diabetes Care, 33, 920-922. https://doi.org/10.2337/dc09-1825
|
[16]
|
Fan, Y., He, D., Liu, S., Qiao, Y., Gao, H. and Xin, L. (2021) Association between Visceral Adipose Index and Risk of Hypertension in a Middle-Aged and Elderly Chinese Population. Nutrition, Metabolism and Cardiovascular Diseases, 31, 2358-2365. https://doi.org/10.1016/j.numecd.2021.04.024
|
[17]
|
Bagyura, Z., Kiss, L., Lux, Á., Csobay-Novák, C., Jermendy, Á.L., Polgár, L., et al. (2020) Association between Coronary Atherosclerosis and Visceral Adiposity Index. Nutrition, Metabolism and Cardiovascular Diseases, 30, 796-803. https://doi.org/10.1016/j.numecd.2020.01.013
|
[18]
|
Poulter, N.R., Prabhakaran, D. and Caulfield, M. (2015) Hypertension. The Lancet, 386, 801-812. https://doi.org/10.1016/s0140-6736(14)61468-9
|
[19]
|
Kim, D.D. and Basu, A. (2016) Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value in Health, 19, 602-613. https://doi.org/10.1016/j.jval.2016.02.008
|
[20]
|
Brauer, P., Gorber, S.C., Shaw, E., Singh, H., Bell, N., Shane, A.R.E., et al. (2015) Recommendations for Prevention of Weight Gain and Use of Behavioural and Pharmacologic Interventions to Manage Overweight and Obesity in Adults in Primary Care. Canadian Medical Association Journal, 187, 184-195. https://doi.org/10.1503/cmaj.140887
|
[21]
|
Müller, M.J. and Geisler, C. (2017) Defining Obesity as a Disease. European Journal of Clinical Nutrition, 71, 1256-1258. https://doi.org/10.1038/ejcn.2017.155
|
[22]
|
Neeland, I.J., Ayers, C.R., Rohatgi, A.K., Turer, A.T., Berry, J.D., Das, S.R., et al. (2013) Associations of Visceral and Abdominal Subcutaneous Adipose Tissue with Markers of Cardiac and Metabolic Risk in Obese Adults. Obesity, 21, E439-E447. https://doi.org/10.1002/oby.20135
|
[23]
|
Chen, J., Talwalkar, J.A., Yin, M., Glaser, K.J., Sanderson, S.O. and Ehman, R.L. (2011) Early Detection of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease by Using MR Elastography. Radiology, 259, 749-756. https://doi.org/10.1148/radiol.11101942
|
[24]
|
Brahimaj, A., Rivadeneira, F., Muka, T., Sijbrands, E.J.G., Franco, O.H., Dehghan, A., et al. (2019) Novel Metabolic Indices and Incident Type 2 Diabetes among Women and Men: The Rotterdam Study. Diabetologia, 62, 1581-1590. https://doi.org/10.1007/s00125-019-4921-2
|
[25]
|
Al-Daghri, N.M., Al-Attas, O.S., Wani, K., Alnaami, A.M., Sabico, S., Al-Ajlan, A., et al. (2015) Sensitivity of Various Adiposity Indices in Identifying Cardiometabolic Diseases in Arab Adults. Cardiovascular Diabetology, 14, Article No. 101. https://doi.org/10.1186/s12933-015-0265-5
|
[26]
|
Zhang, Z., Shi, D., Zhang, Q., Wang, S., Liu, K., Meng, Q., et al. (2018) Visceral Adiposity Index (VAI), a Powerful Predictor of Incident Hypertension in Prehypertensives. Internal and Emergency Medicine, 13, 509-516. https://doi.org/10.1007/s11739-018-1836-8
|
[27]
|
Xue, Y., Shen, Q., Li, C., Dai, Z. and He, T. (2020) The Visceral Adipose Index in Relation to Incidence of Hypertension in Chinese Adults: China Health and Nutrition Survey (CHNS). Nutrients, 12, Article 805. https://doi.org/10.3390/nu12030805
|
[28]
|
Landsberg, L., Aronne, L.J., Beilin, L.J., Burke, V., Igel, L.I., Lloyd-Jones, D., et al. (2012) Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment—A Position Paper of the Obesity Society and the American Society of Hypertension. Obesity, 21, 8-24. https://doi.org/10.1002/oby.20181
|
[29]
|
Kotchen, T.A. (2010) Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management. American Journal of Hypertension, 23, 1170-1178. https://doi.org/10.1038/ajh.2010.172
|
[30]
|
Yaribeygi, H., Farrokhi, F.R., Butler, A.E. and Sahebkar, A. (2018) Insulin Resistance: Review of the Underlying Molecular Mechanisms. Journal of Cellular Physiology, 234, 8152-8161. https://doi.org/10.1002/jcp.27603
|
[31]
|
Hilliard, L.M., Sampson, A.K., Brown, R.D. and Denton, K.M. (2012) The “His and Hers” of the Renin-Angiotensin System. Current Hypertension Reports, 15, 71-79. https://doi.org/10.1007/s11906-012-0319-y
|
[32]
|
Ko, S. and Jung, Y. (2021) Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women. Nutrients, 13, Article 4556. https://doi.org/10.3390/nu13124556
|
[33]
|
Seravalle, G. and Grassi, G. (2017) Obesity and Hypertension. Pharmacological Research, 122, 1-7. https://doi.org/10.1016/j.phrs.2017.05.013
|
[34]
|
Hall, J.E., da Silva, A.A., do Carmo, J.M., Dubinion, J., Hamza, S., Munusamy, S., et al. (2010) Obesity-Induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins. Journal of Biological Chemistry, 285, 17271-17276. https://doi.org/10.1074/jbc.r110.113175
|
[35]
|
Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F.Q., Bombelli, M., Scopelliti, F., et al. (2003) Comparative Effects of Candesartan and Hydrochlorothiazide on Blood Pressure, Insulin Sensitivity, and Sympathetic Drive in Obese Hypertensive Individuals. Journal of Hypertension, 21, 1761-1769. https://doi.org/10.1097/00004872-200309000-00027
|
[36]
|
Liu, J., Yang, X., Yu, S. and Zheng, R. (2018) The Leptin Resistance. In: Advances in Experimental Medicine and Biology, Springer, 145-163. https://doi.org/10.1007/978-981-13-1286-1_8
|